<?xml version="1.0" encoding="UTF-8"?>
<p>This medicinal plant belongs to the family of 
 <italic>Rosaceae</italic> and almost all parts of the plant are used for remedial purposes [
 <xref rid="B126-plants-09-01244" ref-type="bibr">126</xref>]. It is widely used for the treatment of many diseases, including heart muscle cells activation, coronary dilation, regulated blood flow, use as an antioxidant and anti-diabetic, and many others [
 <xref rid="B125-plants-09-01244" ref-type="bibr">125</xref>,
 <xref rid="B126-plants-09-01244" ref-type="bibr">126</xref>]. It contains flavonoids (phenols, phenolic acids, procyanidins, flavonoids, triterpenes, polysaccharides, catecho-lamines) which help in controlling/regulating various diseases [
 <xref rid="B120-plants-09-01244" ref-type="bibr">120</xref>,
 <xref rid="B124-plants-09-01244" ref-type="bibr">124</xref>,
 <xref rid="B125-plants-09-01244" ref-type="bibr">125</xref>,
 <xref rid="B126-plants-09-01244" ref-type="bibr">126</xref>]. Furthermore, it has also showed efficacy to inhibit the ACE-2 receptor and prohibit the entry of virus into the cell [
 <xref rid="B113-plants-09-01244" ref-type="bibr">113</xref>]. in vitro results suggested the use of a 330 µg/mL concentration of 
 <italic>Crataegus microphylla</italic> was able to inhibit the virus binding to the ACE-2 receptor, and their IC
 <sub>50</sub> was observed as 80.9 ± 1.3 [
 <xref rid="B113-plants-09-01244" ref-type="bibr">113</xref>]. The occurrence of some potential bioactive compounds in this medicinal plant and their efficacy against SARS-CoV-2 must be tested for better drug therapy to manage COVID-19.
</p>
